Already registered? Log in now to personalize your experience!
Description
Identifying a therapeutic target, designing a molecule, simulating its effect on a "virtual patient," accelerating clinical trials, and then tailoring treatment to each individual patient: artificial intelligence is revolutionizing the entire healthcare value chain. By compressing research cycles that used to take decades and paving the way for truly personalized medicine, it promises drugs that are faster to develop, more targeted, and potentially less expensive. But this revolution also raises major questions: the reliability and explainability of models, access to health data, the position of European players in the face of American and Chinese giants, and the capacity of our healthcare systems to absorb these innovations. From the lab bench to the patient's bedside, how can France and Europe leverage AI to achieve health and industrial sovereignty? How is it transforming the patient journey and the role of the physician? When the algorithm's recommendations differ from the clinician's opinion, how can trust be built? And if AI becomes patients' first reflex in the future, how can the priority of medical decision-making and the responsibility of healthcare professionals be preserved?
